Is SCRSF or MRK a better dividend investment in 2026?

SCRSF currently yields 100000.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: SCRSF offers higher current income.

What is the dividend yield difference between SCRSF and MRK?

SCRSF has a forward dividend yield of 100000.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 99997.24 percentage points.

Home › Compare › SCRSF vs MRK

SCRSF vs MRK: Dividend Comparison 2026

SCRSF yields 100000.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SCRSF wins by $4.832206901976048e+26M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SCRSF

● Live price

100000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.832206901976048e+26M

Annual income

$482,271,988,201,431,700,000,000,000,000,000.00

Full SCRSF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — SCRSF vs MRK

📍 SCRSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SCRSF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SCRSF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SCRSF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCRSF

Annual income on $10K today (after 15% tax)

$8,500,000.00/yr

After 10yr DRIP, annual income (after tax)

$409,931,189,971,216,900,000,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, SCRSF beats the other by $409,931,189,971,216,900,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCRSF + MRK for your $10,000?

SCRSF: 50%MRK: 50%

100% MRK50/50100% SCRSF

Portfolio after 10yr

$2.416103450988024e+26M

Annual income

$241,135,994,100,715,840,000,000,000,000,000.00/yr

Blended yield

99.80%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SCRSF

No analyst data

Altman Z

-28.1

Piotroski

5/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCRSF buys

MRK buys

No recent congressional trades found for SCRSF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSCRSFMRK

Forward yield	100000.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$4.832206901976048e+26M	$56.8K ✓
Annual income after 10y	$482,271,988,201,431,700,000,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$4.8315851896727036e+26M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SCRSF vs MRK ($10,000, DRIP)

Year	SCRSF Portfolio	SCRSF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$10,010,700	$10,000,000.00	$11,206	$366.19	+$10.00M → SCRSF
2	$9,366,505,842	$9,355,794,392.52	$12,650	$502.35	+$9366.49M → SCRSF
3	$8,191,091,111,834	$8,181,068,950,583.78	$14,407	$694.19	+$8191091.10M → SCRSF
4	$6,695,134,751,499,451	$6,686,370,284,009,789.00	$16,585	$967.82	+$6695134751.48M → SCRSF
5	$5,114,850,040,116,031,000	$5,107,686,245,931,928,000.00	$19,342	$1,363.89	+$5114850040116.01M → SCRSF
6	$3,652,290,278,277,141,000,000	$3,646,817,388,734,216,400,000.00	$22,913	$1,947.19	+$3652290278277141.00M → SCRSF
7	$2,437,583,176,648,375,000,000,000	$2,433,675,226,050,619,000,000,000.00	$27,662	$2,823.89	+$2437583176648375296.00M → SCRSF
8	$1,520,612,508,079,010,700,000,000,000	$1,518,004,294,079,997,000,000,000,000.00	$34,159	$4,173.35	+$1.5206125080790106e+21M → SCRSF
9	$886,637,379,601,106,600,000,000,000,000	$885,010,324,217,461,900,000,000,000,000.00	$43,337	$6,308.80	+$8.866373796011065e+23M → SCRSF
10	$483,220,690,197,604,800,000,000,000,000,000	$482,271,988,201,431,700,000,000,000,000,000.00	$56,776	$9,798.13	+$4.832206901976048e+26M → SCRSF

SCRSF vs MRK: Complete Analysis 2026

SCRSF — Stock

Justera Health Ltd., together with its subsidiaries, operates as a health and wellness management company in Canada. The company operates GoStop, a COVID-19 digital testing platform; and provides COVID-19 screening services to businesses and government organizations. It also operates Juillet Wellness Spas, a full-service wellness centre, that provides skincare, medical grade facials, physiotherapy, body massages, registered massage therapy, acupuncture, and laser hair removal services; and distributes TonyMoly skin care products. In addition, the company offers health supplements, protein products, beauty, and pet care solutions; and provides concierge medical services, including urgent concierge medical care, IV vitamin therapy, medical advisory, and preventive screenings to determine the presence or absence of disease. Justera Health Ltd. was founded in 2020 and is headquartered in Toronto, Canada.

Full SCRSF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this SCRSF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCRSF vs SCHD SCRSF vs JEPI SCRSF vs O SCRSF vs KO SCRSF vs MAIN SCRSF vs JNJ SCRSF vs ABBV SCRSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.